Sam Brusco, Associate Editor11.18.22
Orthofix and SeaSpine announced that current SeaSpine CFO and chief operating officer John Bostjancic will serve as CFO of the new combined company following completion of their pending merger.
Bostjancic has held the roles of CFO and COO of SeaSpine since 2015 and 2022, respectively. He was previously SeaSpine treasurer and senior VP from 2015 to 2022. He was acting CFO if Integra LifeSciences from 2014 through 2015. Prior to that, he was senior VP of global supply chain at Integra, having joined the company in 1999.
“John has been a key leader of SeaSpine dating back to the successful spin-out of the organization in 2015. I am confident his background and experience in the medical device industry coupled with his cultural influence will benefit the newly combined company as we continue to grow,” Keith Valentine, president and CEO of SeaSpine told the press. “I believe John is well positioned to help lead us through the successful integration of the two companies, ensuring accountability across all levels of the organization, as we focus on the key initiatives that will drive growth, scalability and shareholder value.”
The transaction is expected to close in the Q1 2023.
Bostjancic has held the roles of CFO and COO of SeaSpine since 2015 and 2022, respectively. He was previously SeaSpine treasurer and senior VP from 2015 to 2022. He was acting CFO if Integra LifeSciences from 2014 through 2015. Prior to that, he was senior VP of global supply chain at Integra, having joined the company in 1999.
“John has been a key leader of SeaSpine dating back to the successful spin-out of the organization in 2015. I am confident his background and experience in the medical device industry coupled with his cultural influence will benefit the newly combined company as we continue to grow,” Keith Valentine, president and CEO of SeaSpine told the press. “I believe John is well positioned to help lead us through the successful integration of the two companies, ensuring accountability across all levels of the organization, as we focus on the key initiatives that will drive growth, scalability and shareholder value.”
The transaction is expected to close in the Q1 2023.